78 related articles for article (PubMed ID: 10193256)
1. Impact of and research priorities in early onset epilepsy: An investigation of parental concerns.
Lindsay N; Martin J; Adegboye D; Absoud M; Charman T; Tye C
Epilepsy Behav; 2024 Jul; 156():109794. PubMed ID: 38733908
[TBL] [Abstract][Full Text] [Related]
2. How do parents perceive their children's epileptic seizures? Experiences of the first seizure and changes during the course of the epilepsy.
Lange S; Jeschke S; Pauschek J; Charisius M; Makiello P; Bertsche T; Neininger MP; Bertsche A
Epilepsy Behav; 2023 Nov; 148():109459. PubMed ID: 37806289
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Clinical and Genetic Landscape of Angelman Syndrome: Patient-Reported Insights from an Italian Registry.
Carriero PL; Zangari R; Sfreddo E; Ghirardi A; Schieppati A; Barbui T; Biroli F
J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38930051
[No Abstract] [Full Text] [Related]
4. Quality of Life in Angelman Syndrome: A Caregivers' Survey.
Xia NY; Grant ML; Benjamin NL; Valencia I
Pediatr Neurol; 2023 Dec; 149():19-25. PubMed ID: 37757661
[TBL] [Abstract][Full Text] [Related]
5. Living with and managing seizures among parents of children diagnosed with Phelan-McDermid syndrome: a qualitative study using in-depth interviews.
García-Bravo C; Martínez-Piédrola RM; García-Bravo S; Rodríguez-Pérez MP; Martín-Gómez AS; Fernández-Gómez G; Palacios-Ceña D
Eur J Pediatr; 2024 Jan; 183(1):253-262. PubMed ID: 37870610
[TBL] [Abstract][Full Text] [Related]
6. Response to letter to editor: "Knowing when and how to use epilepsy screening questionnaires".
Eaton CB; Thomas RH; Hamandi K; Payne GC; Kerr MP; Linden DEJ; Owen MJ; Cunningham AC; Bartsch U; Struik SS; van den Bree MBM
Epilepsia; 2020 Apr; 61(4):826-827. PubMed ID: 32115693
[No Abstract] [Full Text] [Related]
7. Adult Gene Therapy for Epilepsy in a Model of Angelman Syndrome: Hope or Hype?
Huguenard JR
Epilepsy Curr; 2023; 23(5):312-314. PubMed ID: 37901779
[No Abstract] [Full Text] [Related]
8. 2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects.
Dlugos D; Worrell G; Davis K; Stacey W; Szaflarski J; Kanner A; Sunderam S; Rogawski M; Jackson-Ayotunde P; Loddenkemper T; Diehl B; Fureman B; Dingledine R;
Epilepsy Curr; 2016; 16(3):192-7. PubMed ID: 27330452
[No Abstract] [Full Text] [Related]
9. Translational research for the development of treatment of patients with neurogenetic diseases: An important step for Angelman syndrome.
Dan B
Eur J Paediatr Neurol; 2023 Nov; 47():A2. PubMed ID: 37989651
[No Abstract] [Full Text] [Related]
10. Teaching NeuroImage: Notched Delta and Angelman Syndrome.
Nascimento FA; Thiele EA; Thibert RL
Neurology; 2021 Oct; 97(15):e1543-e1544. PubMed ID: 34031203
[No Abstract] [Full Text] [Related]
11. Epilepsy in Angelman syndrome: A scoping review.
Samanta D
Brain Dev; 2021 Jan; 43(1):32-44. PubMed ID: 32893075
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and epilepsy in genomic imprinting disorders: Angelman syndrome and Prader-Willi syndrome.
Wang TS; Tsai WH; Tsai LP; Wong SB
Ci Ji Yi Xue Za Zhi; 2020; 32(2):137-144. PubMed ID: 32269945
[TBL] [Abstract][Full Text] [Related]
13. Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms.
Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Caltabiano R; Polizzi A
Childs Nerv Syst; 2017 Apr; 33(4):549-560. PubMed ID: 27669695
[No Abstract] [Full Text] [Related]
14. Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms.
Guerrini R; Carrozzo R; Rinaldi R; Bonanni P
Paediatr Drugs; 2003; 5(10):647-61. PubMed ID: 14510623
[TBL] [Abstract][Full Text] [Related]
15. Electro-ophthalmological recovery after withdrawal from vigabatrin.
Graniewski-Wijnands HS; van der Torren K
Doc Ophthalmol; 2002 Mar; 104(2):189-94. PubMed ID: 11999626
[TBL] [Abstract][Full Text] [Related]
16. Parental view of epilepsy in Angelman syndrome: a questionnaire study.
Ruggieri M; McShane MA
Arch Dis Child; 1998 Nov; 79(5):423-6. PubMed ID: 10193256
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman syndrome.
Galván-Manso M; Campistol J; Conill J; Sanmartí FX
Epileptic Disord; 2005 Mar; 7(1):19-25. PubMed ID: 15741136
[TBL] [Abstract][Full Text] [Related]
18. Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options.
Thibert RL; Conant KD; Braun EK; Bruno P; Said RR; Nespeca MP; Thiele EA
Epilepsia; 2009 Nov; 50(11):2369-76. PubMed ID: 19453717
[TBL] [Abstract][Full Text] [Related]
19. Epilepsy in patients with angelman syndrome caused by deletion of the chromosome 15q11-13.
Valente KD; Koiffmann CP; Fridman C; Varella M; Kok F; Andrade JQ; Grossmann RM; Marques-Dias MJ
Arch Neurol; 2006 Jan; 63(1):122-8. PubMed ID: 16401744
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
